260 related articles for article (PubMed ID: 22810172)
1. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
de Haro Moraes C; Figueiredo VN; de Faria AP; Barbaro NR; Sabbatini AR; Quinaglia T; Ferreira-Melo SE; Martins LC; Demacq C; Júnior HM
J Hum Hypertens; 2013 Apr; 27(4):225-30. PubMed ID: 22810172
[TBL] [Abstract][Full Text] [Related]
2. Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension.
de Faria AP; Demacq C; Figueiredo VN; Moraes CH; Santos RC; Sabbatini AR; Barbaro NR; Boer-Martins L; Fontana V; Moreno H
Hypertens Res; 2013 Dec; 36(12):1067-72. PubMed ID: 23966059
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of adipokines related to target organ damage on resistant hypertension.
Sabbatini AR; Faria AP; Barbaro NR; Gordo WM; Modolo RG; Pinho C; Fontana V; Moreno H
J Hum Hypertens; 2014 Jun; 28(6):388-92. PubMed ID: 24284384
[TBL] [Abstract][Full Text] [Related]
4. Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension.
Lacerda L; Faria AP; Fontana V; Moreno H; Sandrim V
Arq Bras Cardiol; 2015 Aug; 105(2):168-75. PubMed ID: 26039662
[TBL] [Abstract][Full Text] [Related]
5. Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes.
Boer-Martins L; Figueiredo VN; Demacq C; Martins LC; Faria AP; Moraes Cde H; Moreno H
Arq Bras Cardiol; 2012 Jul; 99(1):642-8. PubMed ID: 22641394
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone excess and resistance to 24-h blood pressure control.
Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
[TBL] [Abstract][Full Text] [Related]
7. Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension.
Sanders NA; Bertolone C; Jetter TL; Wasmund SL; Croci F; Solano A; Brignole M; Hamdan MH
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):722-6. PubMed ID: 22494504
[TBL] [Abstract][Full Text] [Related]
8. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
[TBL] [Abstract][Full Text] [Related]
9. Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure.
Figueiredo VN; Yugar-Toledo JC; Martins LC; Martins LB; de Faria AP; de Haro Moraes C; Sierra C; Coca A; Moreno H
Blood Press; 2012 Feb; 21(1):31-8. PubMed ID: 22029740
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
Ezzahti M; Moelker A; Friesema EC; van der Linde NA; Krestin GP; van den Meiracker AH
J Hypertens; 2014 Jan; 32(1):135-41. PubMed ID: 24131897
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
[TBL] [Abstract][Full Text] [Related]
12. Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension.
Shlomai G; Sella T; Sharabi Y; Leibowitz A; Grossman E
Hypertens Res; 2014 Dec; 37(12):1037-41. PubMed ID: 24671013
[TBL] [Abstract][Full Text] [Related]
13. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
Quinaglia T; Martins LC; Figueiredo VN; Santos RC; Yugar-Toledo JC; Martin JF; Demacq C; Pimenta E; Calhoun DA; Moreno H
J Hum Hypertens; 2011 Nov; 25(11):656-64. PubMed ID: 21544090
[TBL] [Abstract][Full Text] [Related]
14. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure.
Erdogan D; Icli A; Aksoy F; Akcay S; Ozaydin M; Ersoy I; Varol E; Dogan A
Chronobiol Int; 2013 Oct; 30(8):973-80. PubMed ID: 23834704
[TBL] [Abstract][Full Text] [Related]
15. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
16. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
17. Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men.
Galletti F; D'Elia L; De Palma D; Russo O; Barba G; Siani A; Miller MA; Cappuccio FP; Rossi G; Zampa G; Strazzullo P
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):300-6. PubMed ID: 21920718
[TBL] [Abstract][Full Text] [Related]
18. [Association of leptin with obesity and hypertension in an ethnic Kyrgyz group].
Kerimkulova AS; Lunegova OS; Mirrakhimov AE; Alibaeva NT; Neronova KV; Baĭramukova AA; Mirrakhimov EM
Ter Arkh; 2014; 86(1):49-53. PubMed ID: 24754069
[TBL] [Abstract][Full Text] [Related]
19. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
Gilardini L; Parati G; Sartorio A; Mazzilli G; Pontiggia B; Invitti C
J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228
[TBL] [Abstract][Full Text] [Related]
20. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
